DELRAY BEACH, Fla., Sep 16, 2014 (BUSINESS WIRE) -- VeriTeQ Corporation ("VeriTeQ") (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that more than 1,000 women worldwide have now received Motiva Implant Matrix(R) breast implants with VeriTeQ's Q Inside Safety Technology(TM). Motiva Implant Matrix(R) breast implants, manufactured by Establishment Labs S.A. ("EL"), featuring VeriTeQ's Q Inside Safety Technology(TM) can be safely and accurately identified from outside of the body in a physician's office.
VeriTeQ's FDA cleared Q Inside Safety Technology(TM) acts as an electronic serial number in breast implants and other implantable and reusable medical devices to provide physicians and patients access to secure online databases to retrieve device-specific data, such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data from the medical device manufacturer. Q Inside Safety Technology(TM) may also provide an extra level of protection to the patient in the event of a recall or other safety event.
EL's Motiva Implant Matrix(R) Ergonomix(TM), VelvetSurface(R) PLUS, and SilkSurface(R) PLUS, all with VeriTeQ's Q Inside Safety Technology, have received CE Mark approval.
"This is an important milestone for Motiva and a clear signal to the industry that women value innovation and safety in long-term implantable devices," said Juan Jose Chacon-Quiros, Chief Executive Officer of EL.
"We are very proud of the work we are doing with our partner Establishment Labs to reach this significant milestone for our medical device identification business," said Scott R. Silverman, VeriTeQ's Chairman and Chief Executive Officer. "EL continues to see increased demand for its best-in-class breast implants as both physicians and patients request enhanced identification and other advanced technology options for their medical devices.
